in-pharmatechnologist -- GlaxoSmithKline (GSK) has confirmed that job cuts in its neurosciences group will affect less than 50 people, but half those cuts are coming from the company’s US headquarters in North Carolina.
in-pharmatechnologist -- GlaxoSmithKline (GSK) has confirmed that job cuts in its neurosciences group will affect less than 50 people, but half those cuts are coming from the company’s US headquarters in North Carolina.